全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Rodent Carcinogenicity Dataset

DOI: 10.1155/2013/361615

Full-Text   Cite this paper   Add to My Lib

Abstract:

The rodent carcinogenicity dataset was compiled from the Carcinogenic Potency Database (CPDBAS) and was applied for the classification of quantitative structure-activity relationship (QSAR) models for the prediction of carcinogenicity based on the counter-propagation artificial neural network (CP ANN) algorithm. The models were developed within EU-funded project CAESAR for regulatory use. The dataset contains the following information: common information about chemicals (ID, chemical name, and their CASRN), molecular structure information (SDF files and SMILES), and carcinogenic (toxicological) properties information: carcinogenic potency (TD50_Rat_mg; carcinogen/noncarcinogen) and structural alert (SA) for carcinogenicity based on mechanistic data. Molecular structure information was used to get chemometrics information to calculate molecular descriptors (254 MDL and 784 Dragon descriptors), which were further used in predictive QSAR modeling. The dataset presented in the paper can be used in future research in oncology, ecology, or chemicals' risk assessment. 1. Introduction Rodent carcinogenicity datasets were used to build models to predict carcinogenicity within EC-funded project CAESAR (Project no. 022674 (SSPI)) [1]. CAESAR project was aimed to develop quantitative structure-activity relationship (QSAR) models for the REACH (Registration, Evaluation, Authorization, and restriction of CHemicals) legislation for five endpoints: bioconcentration factor, skin sensitization, carcinogenicity, mutagenicity, and developmental toxicity. REACH regulation requires the evaluation of the risks resulting from the use of chemicals produced in industry and testing of their toxicity. Carcinogenicity is among the toxicological endpoints that pose the highest public concern. The standard bioassays in rodents used to assess the carcinogenic potency of chemicals are time consuming and costly and require the sacrifice of large number of animals. Cancer bioassays should be reduced according to REACH regulation [2], while the Seventh Amendment to the EU cosmetics directive will ban the bioassay for cosmetic ingredients from 2013 [3]. The aim of CAESAR project was to reduce the use of animals as well as the cost associated with toxicity tests. The models predicting carcinogenicity meet the requirements for QSAR models used for regulatory use. Great attention was paid to the quality of data used to build the models; the models were then validated. They are transparent and reproducible and are checked against the OECD principles. The models at the CAESAR's website have

References

[1]  CAESAR Project, http://www.caesar-project.eu/.
[2]  EC, “Directive 2003/15/EC of the European Parliament and of the Council of 27 February 2003 amending Directive 78/786/EEC on the approximation of the laws of the member states relating to cosmetic products,” Official Journal of the European Union L, vol. 66, pp. 26–35, 2003.
[3]  EC, “Corrigendum to regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006,” Official Journal of the European Union L, vol. 136, no. 50, pp. 3–280, 2007.
[4]  N. Fjodorova, M. Vra?ko, M. Novi?, A. Roncaglioni, and E. Benfenati, “New public QSAR model for carcinogenicity,” Chemistry Central Journal, vol. 4, supplement 1, article S3, 2010, http://journal.chemistrycentral.com/content/4/S1/S3/.
[5]  N. Fjodorova, M. Vra?ko, M. Tu?ar et al., “Quantitative and qualitative models for carcinogenicity prediction for non-congeneric chemicals using CP ANN method for regulatory uses,” Molecular Diversity, vol. 14, no. 3, pp. 581–594, 2010.
[6]  N. Fjodorova, M. Vra?ko, A. Jezierska, and M. Novi?, “Counter propagation artificial neural network categorical models for prediction of carcinogenicity for non-congeneric chemicals,” SAR and QSAR in Environmental Research, vol. 21, no. 1-2, pp. 57–75, 2010.
[7]  N. Fjodorova, M. Novi?, A. Roncaglioni, and E. Benfenati, “Evaluating the applicability domain in the case of classification predictive models for carcinogenicity based on the counter propagation artificial neural network,” Journal of Computer-Aided Molecular Design, vol. 25, no. 12, pp. 1147–1158, 2011, http://link.springer.com/article/10.1007%2Fs10822-011-9499-9.
[8]  N. Fjodorova and M. Novi?, “Some findings relevant to the mechanistic interpretation in the case of predictive models for carcinogenicity based on the counter propagation artificial neural network,” Journal of Computer-Aided Molecular Design, vol. 25, no. 12, pp. 1159–1169, 2011, http://link.springer.com/article/10.1007%2Fs10822-011-9500-7.
[9]  E. Benfenati, R. Benigni, D. M. Demarini et al., “Predictive models for carcinogenicity and mutagenicity: frameworks, state-of-the-art, and perspectives,” Journal of Environmental Science and Health. Part C, vol. 27, no. 2, pp. 57–90, 2009.
[10]  CPDBAS: Carcinogenic Potency Database Summary Tables—All Species, 2008, http://www.epa.gov/ncct/dsstox/sdf_cpdbas.html.
[11]  ChemFinder, http://www.cambridgesoft.com/databases/login/?serviceid=128.
[12]  ChemIDPlus, http://chem.sis.nlm.nih.gov/chemidplus/.
[13]  PubChem, http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pccompound.
[14]  R. Benigni, C. Bossa, N. Jeliazkova, T. I. Netzeva, and A. P. Worth, The Benigni/Bossa rulebase for mutagenicity and carcinogenicity- a module of Toxtree. EUR 23241 EN: 1-70, 2008.
[15]  R. Benigni and C. Bossa, “Mechanisms of chemical carcinogenicity and mutagenicity: a review with implications for predictive toxicology,” Chemical Reviews, vol. 111, no. 4, pp. 2507–2536, 2011.
[16]  G. Schüürmann, R. Kühne, F. Kleint, R. Ebert-U, C. Rothenbacher, and P. Herth, “A software system for automatic chemical property estimation from molecular structure,” in Quantitative Structure-Activity Relationships in Environmental Sciences, F. Chen and G. Schüürmann, Eds., pp. 93–114, SETAC Press, Pensacola, Fla, USA, 1997.
[17]  G. Schüürmann, R. Ebert-U, M. Nendza, J. C. Dearden, A. Paschke, and R. Kühne, “Prediction of fate-related compound properties,” in Risk Assessment of Chemicals. An Introduction, K. van Leeuwen and T. Vermeire, Eds., pp. 375–426, Springer Science, Dordrecht, The Netherlands, 2007.
[18]  ChemFinder Ultra 10.0: CambridgeSoft Corp., Cambridge, Mass, USA. FDA SAR Carcinogenicity database, Leadscope Inc., Columbus, Ohio, USA, 2009.
[19]  R. Todeschini and V. Consonni, Handbook of Molecular Descriptors, Willey-VCH, New York, NY, USA, 2000.
[20]  I. V. Tetko, J. Gasteiger, R. Todeschini et al., “Virtual computational chemistry laboratory—design and description,” Journal of Computer-Aided Molecular Design, vol. 19, no. 6, pp. 453–463, 2005.
[21]  MDL-QSARv version 2.2., 2002-2004. MDL Information Systems Inc., San Leandro, Calif, USA, 94577, http://www.drugdiscoveryonline.com/buyersguide.mvc/sponsors.
[22]  Dragon home page, http://www.talete.mi.it/products/dragon_description.htm.
[23]  L. B. Kier and L. H. Hall, Structure Description: The Electrotopological State, Academic Press, New York, NY, USA, 1999.
[24]  L. B. Kier and L. H. Hall, “Database organization and searching with E-State indices,” SAR and QSAR in Environmental Research, vol. 12, no. 1-2, pp. 55–74, 2001.
[25]  L. B. Kier and L. H. Hall, “The electrotopological state: structure modeling for QSAR and database analysis,” in Topological Indices and Related Descriptors in QSAR and QSPR, J. Devillers and A. T. Balaban, Eds., pp. 491–562, Gordon and Breach, Reading, UK, 1999.
[26]  F. Ros, M. Pintore, and J. R. Chrétien, “Molecular descriptor selection combining genetic algorithms and fuzzy logic: application to database mining procedures,” Chemometrics and Intelligent Laboratory Systems, vol. 63, no. 1, pp. 15–26, 2002.
[27]  T. Hill and P. Lewicki, STATISTICS Methods and Applications, StatSoft, Tulsa, Okla, USA, 2007.
[28]  Electronic Version, Electronic Statistics Textbook, StatSoft, Tulsa, Okla, USA, 2007, http://www.statsoft.com/textbook/.
[29]  J. Taskinen and J. Yliruusi, “Prediction of physicochemical properties based on neural network modelling,” Advanced Drug Delivery Reviews, vol. 55, no. 9, pp. 1163–1183, 2003.
[30]  J. Zupan, M. Novi?, and I. Ruisánchez, “Kohonen and counterpropagation artificial neural networks in analytical chemistry,” Chemometrics and Intelligent Laboratory Systems, vol. 38, no. 1, pp. 1–23, 1997.
[31]  J. Zupan and J. Gasteiger, Neural Networks in Chemistry and Drug Design, Wiley-VCH, Weinheim, Germany, 2nd edition, 1999.
[32]  J. Zupan, M. Novi?, and I. Ruisánchez, “Kohonen and counterpropagation artificial neural networks in analytical chemistry,” Chemometrics and Intelligent Laboratory Systems, vol. 38, no. 1, pp. 1–23, 1997.
[33]  P. Mazzatorta, M. Vra?ko, A. Jezierska, and E. Benfenati, “Modeling toxicity by using supervised Kohonen neural networks,” Journal of Chemical Information and Computer Sciences, vol. 43, no. 2, pp. 485–492, 2003.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133